Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences.
OBJECTIVE
The aim of this pilot study was to evaluate a magnetically labeled water perfusion imaging technique as a non-contrast-enhanced approach to demonstrate the uterine artery, its branches, and to assess the cervical uterine blood flow in healthy volunteers and in patients with advanced uterine cervical carcinoma (FIGO IIB-IVA).


METHODS
Seven healthy volunteers (mean age, 29 years) and twenty-two patients (mean age, 52 years) with advanced cancer of the uterine cervix (FIGO IIB-IVA) were prospectively examined by magnetically labeled water perfusion imaging at different inversion delay times (300-900 ms). The magnetic resonance imaging (MRI) findings of all patients were matched to the findings of contrast-enhanced dynamic MRI and multiple biopsies (n = 5) and/or surgical whole mount specimens (n = 17), which were available in all patients.


RESULTS
The uterine artery was well visualized with short inversion delay times of 300-500 ms. It was characterized as single or multiple helical loops before dividing into its intracervical branches. The intracervical branching was observed at inversion delay times of 500-700 ms. With longer inversion delay times, arterial signal enhancement disappeared and cervical tissue enhancement was noted. Enhancement of benign tissue was observed at inversion delay times of 1100-1700 ms and in malignant tissue at shorter inversion delay times of 900-1300 ms. The maximum of this diffuse signal enhancement of benign tissue was seen at inversion delay times of 1500 ms (1100-1700 ms) in malignant tissue at significantly (p < 0.5) shorter inversion delay times of 1100 ms (900-1300 ms).


CONCLUSIONS
Our preliminary results show that the vascular supply and blood flow of the normal uterine cervix and of advanced cervical cancer can be assessed by magnetically labeled water perfusion imaging and that malignant cervical tissue is earlier and stronger perfused than normal cervical tissue.
Hawighorst
H
H
Department of Radiological Diagnostics and Therapy, German Cancer Research Center, Heidelberg. H.Hawighorst@dkfz-heidelberg.de
Bock
M
M
Knopp
M V
MV
Essig
M
M
Schoenberg
S O
SO
Knapstein
P G
PG
Schad
L R
LR
van Kaick
G
G
D000328:Adult; D000368:Aged; D001158:Arteries / Q000473:pathology; D001783:Blood Flow Velocity / Q000502:physiology; D002584:Cervix Uteri / Q000098:blood supply*; D003287:Contrast Media; D005260:Female; D019786:Gadolinium DTPA; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007089:Image Enhancement / Q000295:instrumentation*; D008279:Magnetic Resonance Imaging / Q000295:instrumentation*; D008875:Middle Aged; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic / Q000175:diagnosis*; D010477:Perfusion; D012680:Sensitivity and Specificity; D002583:Uterine Cervical Neoplasms / Q000098:blood supply* / Q000175:diagnosis / Q000473:pathology; D014599:Uterus / Q000098:blood supply*; D014867:Water
D003287:Contrast Media; D014867:Water; D019786:Gadolinium DTPA